New insider activity at Ultralife ( (ULBI) ) has taken place on August 21, 2025.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Director Bradford Whitmore has made a significant investment in Ultralife by purchasing 58,664 shares of the company’s stock, amounting to a total value of $386,751.
Recent Updates on ULBI stock
Ultralife’s recent earnings call and financial reports highlighted both achievements and challenges. The company saw a 13% increase in Q2 sales to $48.6 million, primarily driven by the acquisition of Electrochem Solutions, Inc., although organic sales in the Battery & Energy Products segment remained flat and the Communication Systems segment experienced a significant revenue decline due to delayed purchase orders. The gross margin dropped to 23.9%, impacted by tariffs and unfavorable product mix shifts. Despite these challenges, Ultralife made progress in debt reduction, paying down $2.7 million of acquisition debt, and continued investing in new product development. The management remains optimistic about future growth, expecting a rebound in the Communication Systems segment and benefits from increased defense spending.
Spark’s Take on ULBI Stock
According to Spark, TipRanks’ AI Analyst, ULBI is a Neutral.
Ultralife’s overall stock score reflects a stable financial position with strong balance sheet metrics but challenges in profitability and cash flow. Technical analysis indicates bearish momentum, while valuation metrics suggest the stock is relatively expensive. The earnings call highlighted both growth opportunities and significant challenges, balancing the overall outlook.
To see Spark’s full report on ULBI stock, click here.
More about Ultralife
YTD Price Performance: -10.69%
Average Trading Volume: 111,948
Technical Sentiment Signal: Strong Sell
Current Market Cap: $110.7M